226 related articles for article (PubMed ID: 31479669)
1. Development of a conserved chimeric vaccine based on helper T-cell and CTL epitopes for induction of strong immune response against Schistosoma mansoni using immunoinformatics approaches.
Rahmani A; Baee M; Rostamtabar M; Karkhah A; Alizadeh S; Tourani M; Nouri HR
Int J Biol Macromol; 2019 Dec; 141():125-136. PubMed ID: 31479669
[TBL] [Abstract][Full Text] [Related]
2. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
[TBL] [Abstract][Full Text] [Related]
3. Immuno-informatics based approaches to design a novel multi epitope-based vaccine for immune response reinforcement against Leptospirosis.
Validi M; Karkhah A; Prajapati VK; Nouri HR
Mol Immunol; 2018 Dec; 104():128-138. PubMed ID: 30448609
[TBL] [Abstract][Full Text] [Related]
4. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
Saadi M; Karkhah A; Nouri HR
Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
[TBL] [Abstract][Full Text] [Related]
5. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against
Sanches RCO; Tiwari S; Ferreira LCG; Oliveira FM; Lopes MD; Passos MJF; Maia EHB; Taranto AG; Kato R; Azevedo VAC; Lopes DO
Front Immunol; 2021; 12():621706. PubMed ID: 33737928
[TBL] [Abstract][Full Text] [Related]
7. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
8. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
Dong R; Chu Z; Yu F; Zha Y
Front Immunol; 2020; 11():1784. PubMed ID: 32849643
[TBL] [Abstract][Full Text] [Related]
9. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
10. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach.
Mahmud S; Rafi MO; Paul GK; Promi MM; Shimu MSS; Biswas S; Emran TB; Dhama K; Alyami SA; Moni MA; Saleh MA
Sci Rep; 2021 Jul; 11(1):15431. PubMed ID: 34326355
[TBL] [Abstract][Full Text] [Related]
11. Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells.
Fonseca CT; Cunha-Neto E; Kalil J; Jesus AR; Correa-Oliveira R; Carvalho EM; Oliveira SC
Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):63-6. PubMed ID: 15486637
[TBL] [Abstract][Full Text] [Related]
12. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
13. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
14. Rational selection of immunodominant and preserved epitope Sm043300e from Schistosoma mansoni and design of a chimeric molecule for biotechnological purposes.
de Souza C; Lopes MD; De Oliveira FM; Passos MJF; Ferreira LCG; Faria BF; Villar JAFP; Junior MC; Taranto AG; Dos Santos LL; Fonseca CT; de Oliveira Lopes D
Mol Immunol; 2018 Jan; 93():133-143. PubMed ID: 29175593
[TBL] [Abstract][Full Text] [Related]
15. Identification of the immunodominant T cell epitope of p38, a major egg antigen, and characterization of the epitope-specific Th responsiveness during murine schistosomiasis mansoni.
Chen Y; Boros DL
J Immunol; 1998 Jun; 160(11):5420-7. PubMed ID: 9605143
[TBL] [Abstract][Full Text] [Related]
16. Biochemical analysis and identification of linear B-cell epitopes from recombinant Sm21.7 antigen from Schistosoma mansoni.
Rezende CMF; Coitinho JB; Costa M; Silva MR; Giusta M; Oliveira-Prado R; Corrêa-Oliveira R; Nagem R; Goes AM
Mol Immunol; 2018 Sep; 101():29-37. PubMed ID: 29857222
[TBL] [Abstract][Full Text] [Related]
17. Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine.
Dorosti H; Eslami M; Negahdaripour M; Ghoshoon MB; Gholami A; Heidari R; Dehshahri A; Erfani N; Nezafat N; Ghasemi Y
J Biomol Struct Dyn; 2019 Aug; 37(13):3524-3535. PubMed ID: 30634893
[No Abstract] [Full Text] [Related]
18.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
19. Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide.
Pancré V; Gras-Masse H; Delanoye A; Herno J; Capron A; Auriault C
Scand J Immunol; 1996 Nov; 44(5):485-92. PubMed ID: 8947600
[TBL] [Abstract][Full Text] [Related]
20. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]